We report on a patient with a deletion of 18q23. At both 2 and 4 years
of age, she displayed few of the facial features or other clinical fe
atures associated with the 18q- syndrome. Fluorescent in situ hybridis
ation and microsatellite marker and RFLP analysis were performed to ch
aracterise the extent of the deletion, and a terminal deletion of 18q2
3 was confirmed. The deleted region includes the gene for myelin basic
protein, suggesting that hemizygosity of this gene does not invariabl
y lead to mental and developmental delay. The clinical presentation of
this patient suggests that either she is not deleted for the genes in
volved in the 18q- clinical phenotype or this patient represents one e
nd of the spectrum of the clinical variability seen with 18q terminal
deletions.